ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.
Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
For our Members, please find below the list of our latest Model Portfolio changes.
IPL:ASX is now under Algo Engine buy conditions and has been added to the ASX 100 model portfolio.
Traders should begin tracking IPL for a turn higher in the short-term momentum indicators and look for buying interest to increase near the $2.30 support level.
Pro Medicus remains under algo engine buy conditions after rallying from the November entry level at $30.
The current retracement from $50 to $39 means investors should now be watching the short-term momentum indicators for a turn higher. We continue to like the long-term growth profile of Pro Medicus.
For more detail on the strategy, please call our office on 1300 614 002.
ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.
Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
For our Members, please find below the list of our latest Model Portfolio changes.
Pro Medicus remains under algo engine buy conditions after rallying from the November entry level at $30.
The current retracement from $50 to $41 means investors should now be watching the short-term momentum indicators for a turn higher. We continue to like the long-term growth profile of Pro Medicus.
For more detail on the strategy, please call our office on 1300 614 002.
Level 29 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.